{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:17:41Z","timestamp":1768004261299,"version":"3.49.0"},"reference-count":271,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,11]]},"DOI":"10.18632\/oncotarget.15201","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T05:47:01Z","timestamp":1486619221000},"page":"25756-25782","source":"Crossref","is-referenced-by-count":39,"title":["Molecular markers of paragangliomas\/pheochromocytomas"],"prefix":"10.18632","volume":"8","author":[{"given":"Svetlana O.","family":"Zhikrivetskaya","sequence":"first","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiya V.","family":"Snezhkina","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Zaretsky","sequence":"additional","affiliation":[{"name":"M.M. Shemyakin - Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris Y.","family":"Alekseev","sequence":"additional","affiliation":[{"name":"National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly V.","family":"Pokrovsky","sequence":"additional","affiliation":[{"name":"A.V. Vishnevsky Institute of Surgery, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Golovyuk","sequence":"additional","affiliation":[{"name":"A.V. Vishnevsky Institute of Surgery, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya V.","family":"Melnikova","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg A.","family":"Stepanov","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"},{"name":"National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry V.","family":"Kalinin","sequence":"additional","affiliation":[{"name":"A.V. Vishnevsky Institute of Surgery, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Moskalev","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Krasnov","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Dmitriev","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Kudryavtseva","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia"},{"name":"National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"Pacak","year":"2010","journal-title":"Pancreas"},{"key":"2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1445-5994.2000.tb04358.x","article-title":"Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland","volume":"30","author":"Hilton","year":"2000","journal-title":"Aust N Z J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7","article-title":"Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal","volume":"88","author":"Cornelisse","year":"2000","journal-title":"Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00007611-199012000-00010","article-title":"Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis","volume":"83","author":"Houn","year":"1990","journal-title":"South Med J"},{"key":"5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2007-970410","article-title":"Diagnostic management of benign and malignant pheochromocytoma","volume":"115","author":"Lehnert","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Di Trapani","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes","volume":"44","author":"Robledo","year":"2012","journal-title":"Horm Metab Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Smith","year":"2002","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Rohmer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/hmg\/dds374","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma","volume":"21","author":"Favier","year":"2012","journal-title":"Hum Mol Genet"},{"key":"11","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Bignon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","article-title":"Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas","volume":"21","author":"Gimm","year":"2012","journal-title":"Hum Mol Genet"},{"key":"13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/ERC-13-0101","article-title":"In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas","volume":"20","author":"Dahia","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Devilee","year":"2000","journal-title":"Science"},{"key":"15","first-page":"72","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Moore","year":"2005","journal-title":"PLoS Genet"},{"key":"16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","article-title":"Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies","volume":"23","author":"Grossman","year":"2012","journal-title":"Endocr Pathol"},{"key":"17","first-page":"625","article-title":"[Genetics of paragangliomas and pheochromocytomas]","volume":"28","author":"Gimenez-Roqueplo","year":"2012","journal-title":"Med Sci (Paris)"},{"key":"18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.beem.2010.10.004","article-title":"Pheochromocytomas: the (pseudo)-hypoxia hypothesis","volume":"24","author":"Gimenez-Roqueplo","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"19","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"de la Vega","year":"2010","journal-title":"Mol Endocrinol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00518-9","article-title":"HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus","volume":"107","author":"Semenza","year":"2001","journal-title":"Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.moh.0000219663.88409.35","article-title":"Hypoxia-inducible factors, hypoxia, and tumor angiogenesis","volume":"13","author":"Simon","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"22","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","article-title":"Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene","volume":"93","author":"Linehan","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Goldberg","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Kaelin","year":"2001","journal-title":"Science"},{"key":"26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Ratcliffe","year":"1999","journal-title":"Nature"},{"key":"28","first-page":"S251","article-title":"HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors","volume":"63","author":"Pacak","year":"2014","journal-title":"Physiol Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Pacak","year":"2015","journal-title":"J Mol Med (Berl)"},{"key":"30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","article-title":"Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas","volume":"95","author":"Dinjens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/jc.2009-2245","article-title":"Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas","volume":"95","author":"Dahia","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Li","year":"1993","journal-title":"Science"},{"key":"33","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1038\/onc.2011.179","article-title":"Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer","volume":"30","author":"Tian","year":"2011","journal-title":"Oncogene"},{"key":"34","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1210\/jc.2014-1870","article-title":"SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma\/paraganglioma","volume":"100","author":"Favier","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","article-title":"The VHL\/HIF axis in clear cell renal carcinoma","volume":"23","author":"Kaelin","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma","volume":"25","author":"Ratcliffe","year":"2005","journal-title":"Mol Cell Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Simon","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2274","article-title":"The interplay between MYC and HIF in cancer","volume":"8","author":"Yustein","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1158\/0008-5472.CAN-11-0757","article-title":"VHL gene mutations and their effects on hypoxia inducible factor HIFalpha: identification of potential driver and passenger mutations","volume":"71","author":"Moch","year":"2011","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations","volume":"91","author":"Hodgson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"41","doi-asserted-by":"crossref","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg effect is genetically determined in inherited pheochromocytomas","volume":"4","author":"Lib\u00e9","year":"2009","journal-title":"PloS One"},{"key":"42","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Pita","year":"2013","journal-title":"Hum Mol Genet"},{"key":"43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMc1211953","article-title":"HIF2A mutations in paraganglioma with polycythemia","volume":"367","author":"Gimenez-Roqueplo","year":"2012","journal-title":"N Engl J Med"},{"key":"44","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","author":"Pacak","year":"2012","journal-title":"N Engl J Med"},{"key":"45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","article-title":"Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene","volume":"1","author":"Kaelin","year":"2011","journal-title":"Cancer Discov"},{"key":"46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Kaelin","year":"2001","journal-title":"Hum Mol Genet"},{"key":"47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Iliopoulos","year":"1998","journal-title":"Mol Cell"},{"key":"48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1073\/pnas.95.3.993","article-title":"The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal","volume":"95","author":"Klausner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jso.20177","article-title":"Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor","volume":"89","author":"Larsson","year":"2005","journal-title":"J Surg Oncol"},{"key":"50","first-page":"4957","article-title":"von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids","volume":"58","author":"Kerbel","year":"1998","journal-title":"Cancer Res"},{"key":"51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.21.3.865-874.2001","article-title":"VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling","volume":"21","author":"Burk","year":"2001","journal-title":"Mol Cell Biol"},{"key":"52","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/MCB.24.8.3251-3261.2004","article-title":"pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development","volume":"24","author":"Ohh","year":"2004","journal-title":"Mol Cell Biol"},{"key":"53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.1995.03530140061033","article-title":"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II","volume":"274","author":"Brauch","year":"1995","journal-title":"JAMA"},{"key":"54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/jmg.32.11.885","article-title":"Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma","volume":"32","author":"Maher","year":"1995","journal-title":"J Med Genet"},{"key":"55","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2005-2178","article-title":"Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?","volume":"91","author":"Gagel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"56","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","article-title":"A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma","volume":"98","author":"Korbonits","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/cge.12304","article-title":"Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma\/paraganglioma in Korea","volume":"86","author":"Kim","year":"2014","journal-title":"Clin Genet"},{"key":"58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Andia-Melero","year":"2015","journal-title":"J Med Genet"},{"key":"59","doi-asserted-by":"crossref","first-page":"E1661","DOI":"10.1210\/jc.2013-1636","article-title":"Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1alpha\/miR-210 signaling pathway","volume":"98","author":"Chiara","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"60","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cen.12074","article-title":"Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma","volume":"78","author":"Armstrong","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmg.2015.05.008","article-title":"Germline mutations and genotype-phenotype associations in head and neck paraganglioma patients with negative family history in China","volume":"58","author":"Wu","year":"2015","journal-title":"Eur J Med Genet"},{"key":"62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/ERC-11-0369","article-title":"Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients","volume":"19","author":"Carrara","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"63","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype","volume":"3","author":"Maher","year":"1994","journal-title":"Hum Mol Genet"},{"key":"64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Moore","year":"1996","journal-title":"J Med Genet"},{"key":"65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function","volume":"284","author":"Pavletich","year":"1999","journal-title":"Science"},{"key":"66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0005-2728(01)00228-6","article-title":"Inborn errors of complex II\u2014unusual human mitochondrial diseases","volume":"1553","author":"R\u00f6tig","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1582-4934.2010.01238.x","article-title":"Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL","volume":"15","author":"Kim","year":"2011","journal-title":"J Cell Mol Med"},{"key":"68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1079605","article-title":"Architecture of succinate dehydrogenase and reactive oxygen species generation","volume":"299","author":"Iwata","year":"2003","journal-title":"Science"},{"key":"69","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.378","article-title":"SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy","volume":"41","author":"Zeviani","year":"2009","journal-title":"Nat Genet"},{"key":"70","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Kremer","year":"2009","journal-title":"Science"},{"key":"71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12022-013-9269-4","article-title":"Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas","volume":"24","author":"Matias-Guiu","year":"2013","journal-title":"Endocr Pathol"},{"key":"72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10689-010-9402-1","article-title":"Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma","volume":"10","author":"Bayley","year":"2011","journal-title":"Fam Cancer"},{"key":"73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Vriends","year":"2010","journal-title":"Lancet Oncol"},{"key":"74","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2265.2011.04097.x","article-title":"Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients","volume":"75","author":"Vriends","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","article-title":"SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma","volume":"17","author":"Cremers","year":"2011","journal-title":"Clin Cancer Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1066896914537683","article-title":"Hereditary Pheochromocytoma","volume":"22","author":"Taveira-Gomes","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"77","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Favier","year":"2010","journal-title":"Hum Mol Genet"},{"key":"78","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Tissier","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"79","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma","volume":"99","author":"S\u00f6derkvist","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"80","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00405-014-3141-0","article-title":"Management of vagal paragangliomas: review of 17 patients","volume":"272","author":"Scola Yurrita","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"81","first-page":"5615","article-title":"COMETE Network. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Jeunemaitre","year":"2003","journal-title":"Cancer Res"},{"key":"82","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Murday","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"Nathanson","year":"2012","journal-title":"Cancer Genet"},{"key":"84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anorl.2013.05.003","article-title":"Malignant head\/neck paragangliomas. Comparative study","volume":"131","author":"Oker","year":"2014","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/EJE-11-0497","article-title":"The genetics of phaeochromocytoma: using clinical features to guide genetic testing","volume":"166","author":"Maher","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"86","first-page":"1321","article-title":"SDHB gene mutation in a carotid body paraganglioma: case report and review of the paraganglioma syndromes","volume":"28","author":"Vaccaro","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"87","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000000283","article-title":"The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas","volume":"260","author":"Kebebew","year":"2014","journal-title":"Ann Surg"},{"key":"88","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Cybulla","year":"2005","journal-title":"JAMA"},{"key":"89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0028-1103123","article-title":"Clinical features of paraganglioma syndromes","volume":"19","author":"Schipper","year":"2009","journal-title":"Skull Base"},{"key":"90","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/path.1461","article-title":"SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology","volume":"201","author":"Cornelisse","year":"2003","journal-title":"J Pathol"},{"key":"91","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1002\/hed.23670","article-title":"Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma","volume":"36","author":"Han","year":"2014","journal-title":"Head Neck"},{"key":"92","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","article-title":"International Carney Triad and Carney-Stratakis Syndrome Consortium. Familial gastrointestinal stromal tumors and germ-line mutations","volume":"357","author":"Stratakis","year":"2007","journal-title":"N Engl J Med"},{"key":"93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","article-title":"Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad","volume":"21","author":"Maher","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"94","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Favier","year":"2011","journal-title":"Hum Mol Genet"},{"key":"95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Gottlieb","year":"2005","journal-title":"Cancer Cell"},{"key":"96","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Ratcliffe","year":"2001","journal-title":"Science"},{"key":"97","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiong","year":"2012","journal-title":"Genes Dev"},{"key":"98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Bertherat","year":"2013","journal-title":"Cancer Cell"},{"key":"99","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","author":"Lasota","year":"2013","journal-title":"Cancer Discov"},{"key":"100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molcel.2013.05.003","article-title":"The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling","volume":"51","author":"Chandel","year":"2013","journal-title":"Mol Cell"},{"key":"101","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/MCB.00483-09","article-title":"Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species","volume":"29","author":"Trepel","year":"2009","journal-title":"Mol Cell Biol"},{"key":"102","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/hmg\/ddm275","article-title":"Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma","volume":"16","author":"Maher","year":"2007","journal-title":"Hum Mol Genet"},{"key":"103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/0008-5472.203.65.1","article-title":"A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis","volume":"65","author":"Ishii","year":"2005","journal-title":"Cancer Res"},{"key":"104","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.01338-07","article-title":"Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis","volume":"28","author":"Schumacker","year":"2008","journal-title":"Mol Cell Biol"},{"key":"105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Bevan","year":"2002","journal-title":"Nat Genet"},{"key":"106","doi-asserted-by":"publisher","first-page":"38777","DOI":"10.18632\/oncotarget.6091","article-title":"Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma\/pheochromocytoma and smooth muscle tumors","volume":"6","author":"Frizzell","year":"2015","journal-title":"Oncotarget"},{"key":"107","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Guillaud-Bataille","year":"2014","journal-title":"Hum Mol Genet"},{"key":"108","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Gardie","year":"2008","journal-title":"N Engl J Med"},{"key":"109","first-page":"73","article-title":"Mutation analysis of HIF prolyl hydroxylases (PHD\/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility","volume":"18","author":"Latif","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.cellbio.12.1.55","article-title":"Ah receptor signaling pathways","volume":"12","author":"Bradfield","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"111","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pa.35.040195.001515","article-title":"The aryl hydrocarbon receptor complex","volume":"35","author":"Hankinson","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"112","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0092-8674(95)90113-2","article-title":"New models in vogue for circadian clocks","volume":"83","author":"Millar","year":"1995","journal-title":"Cell"},{"key":"113","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80245-7","article-title":"Positional cloning of the mouse circadian clock gene","volume":"89","author":"Takahashi","year":"1997","journal-title":"Cell"},{"key":"114","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1101\/gad.10.1.93","article-title":"trachealess encodes a bHLH-PAS protein that is an inducer of tracheal cell fates in Drosophila","volume":"10","author":"Shilo","year":"1996","journal-title":"Genes Dev"},{"key":"115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1101\/gad.10.1.103","article-title":"Tubulogenesis in Drosophila: a requirement for the trachealess gene product","volume":"10","author":"Andrew","year":"1996","journal-title":"Genes Dev"},{"key":"116","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/14728222.2013.775253","article-title":"Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target","volume":"17","author":"Kudryavtseva","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"117","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"McKnight","year":"1998","journal-title":"Genes Dev"},{"key":"118","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-1217","article-title":"First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome","volume":"98","author":"Pacak","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"119","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","author":"Prchal","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Gimenez-Roqueplo","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"121","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"Hewitson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"122","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling","volume":"296","author":"Pavletich","year":"2002","journal-title":"Science"},{"key":"123","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1210\/jc.2013-2191","article-title":"The genetic landscape of pheochromocytomas and paragangliomas: somatic mutations take center stage","volume":"98","author":"Dahia","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"124","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Zhuang","year":"2013","journal-title":"J Clin Oncol"},{"key":"125","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome","volume":"99","author":"Gimenez-Roqueplo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0014-4835(86)80013-6","article-title":"Multiple NADPH-producing pathways control glutathione (GSH) content in retina","volume":"43","author":"Solomon","year":"1986","journal-title":"Exp Eye Res"},{"key":"127","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Farrell","year":"2006","journal-title":"Science"},{"key":"128","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Rasheed","year":"2008","journal-title":"Science"},{"key":"129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Su","year":"2010","journal-title":"Cancer Cell"},{"key":"130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1097-0347(199808)20:5<374::AID-HED3>3.0.CO;2-V","article-title":"Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level","volume":"20","author":"Labastida-Almendaro","year":"1998","journal-title":"Head Neck"},{"key":"131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Guan","year":"2009","journal-title":"Science"},{"key":"132","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Looper","year":"2012","journal-title":"Nature"},{"key":"133","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/ncomms4423","article-title":"Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases","volume":"5","author":"Schofield","year":"2014","journal-title":"Nat Commun"},{"key":"134","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.29080","article-title":"Oncometabolites-driven tumorigenesis: From genetics to targeted therapy","volume":"135","author":"Favier","year":"2014","journal-title":"Int J Cancer"},{"key":"135","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ng.1004","article-title":"Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome","volume":"43","author":"Sangiorgi","year":"2011","journal-title":"Nat Genet"},{"key":"136","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Guryanova","year":"2012","journal-title":"Nature"},{"key":"137","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Wolniak","year":"2010","journal-title":"Cancer Cell"},{"key":"138","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Liu","year":"2011","journal-title":"Cancer Cell"},{"key":"139","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","author":"Mendola","year":"2010","journal-title":"JAMA"},{"key":"140","first-page":"257","article-title":"Malate dehydrogenases\u2014structure and function","volume":"21","author":"Antalik","year":"2002","journal-title":"Gen Physiol Biophys"},{"key":"141","doi-asserted-by":"publisher","first-page":"44879","DOI":"10.18632\/oncotarget.9821","article-title":"Mitochondrial dysfunction and oxidative stress in aging and cancer","volume":"7","author":"Snezhkina","year":"2016","journal-title":"Oncotarget"},{"key":"142","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10545-008-1042-3","article-title":"L:-2-Hydroxyglutaric aciduria, a disorder of metabolite repair","volume":"32","author":"Veiga-da-Cunha","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"143","first-page":"107","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","author":"Villar-Vicente","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"144","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/carcin\/bgt209","article-title":"HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression","volume":"34","author":"Ralph","year":"2013","journal-title":"Carcinogenesis"},{"key":"145","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/MCB.01223-06","article-title":"Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro","volume":"27","author":"Simon","year":"2007","journal-title":"Mol Cell Biol"},{"key":"146","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4161\/cc.3.10.1164","article-title":"Oncogenic mutations of PIK3CA in human cancers","volume":"3","author":"Velculescu","year":"2004","journal-title":"Cell Cycle"},{"key":"147","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000111501","article-title":"Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell line","volume":"87","author":"Grossman","year":"2008","journal-title":"Neuroendocrinology"},{"key":"148","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2009.09.027","article-title":"The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells","volume":"315","author":"Shimon","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"149","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj20020838","article-title":"Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells","volume":"368","author":"MacKintosh","year":"2002","journal-title":"Biochem J"},{"key":"150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Sonenberg","year":"2001","journal-title":"Genes Dev"},{"key":"151","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"Hinnebusch","year":"2009","journal-title":"Cell"},{"key":"152","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Pandolfi","year":"2004","journal-title":"Nat Med"},{"key":"153","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Ruggero","year":"2010","journal-title":"Cancer Cell"},{"key":"154","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/1535-7163.MCT-10-0413","article-title":"Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis","volume":"9","author":"Graff","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"155","doi-asserted-by":"crossref","first-page":"11988","DOI":"10.1073\/pnas.1310230110","article-title":"Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers","volume":"110","author":"Ruggero","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"156","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"Felsher","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"157","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Lowe","year":"2004","journal-title":"Nature"},{"key":"158","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1677\/ERC-09-0316","article-title":"SDHB loss predicts malignancy in pheochromocytomas\/sympathethic paragangliomas, but not through hypoxia signalling","volume":"17","author":"Perren","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"159","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1073\/pnas.0802785105","article-title":"Activation of PI3K\/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1","volume":"105","author":"Yuan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2006.06.013","article-title":"Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism","volume":"38","author":"Cornelisse","year":"2007","journal-title":"Hum Pathol"},{"key":"161","doi-asserted-by":"crossref","first-page":"19297","DOI":"10.1074\/jbc.M905866199","article-title":"Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells","volume":"275","author":"de Franciscis","year":"2000","journal-title":"J Biol Chem"},{"key":"162","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.onc.1200831","article-title":"Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations","volume":"14","author":"Billaud","year":"1997","journal-title":"Oncogene"},{"key":"163","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"McCormick","year":"1990","journal-title":"Cell"},{"key":"164","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3835(03)00456-7","article-title":"RET and neuroendocrine tumors","volume":"204","author":"Takahashi","year":"2004","journal-title":"Cancer Lett"},{"key":"165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Tunnacliffe","year":"1993","journal-title":"Nature"},{"key":"166","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/MCB.15.3.1613","article-title":"Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations","volume":"15","author":"Takahashi","year":"1995","journal-title":"Mol Cell Biol"},{"key":"167","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B","volume":"267","author":"Di Fiore","year":"1995","journal-title":"Science"},{"key":"168","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Jimenez","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"169","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.10205","article-title":"Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course","volume":"94","author":"Baudin","year":"2002","journal-title":"Cancer"},{"key":"170","unstructured":"Pasquali, Di Matteo, Renzullo, Accardo, Esposito, Barbato, Colantuoni, Circelli, Conzo. Multiple endocrine neoplasia, the old and the new: a mini review. Il Giornale di chirurgia. 2012; 33:370\u2013373."},{"key":"171","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/humu.22170","article-title":"Multiple functional effects of RET kinase domain sequence variants in Hirschsprung disease","volume":"34","author":"Mulligan","year":"2013","journal-title":"Hum Mutat"},{"key":"172","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"O\u2019Connell","year":"1990","journal-title":"Cell"},{"key":"173","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins","volume":"63","author":"Collins","year":"1990","journal-title":"Cell"},{"key":"174","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Downward","year":"1992","journal-title":"Nature"},{"key":"175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/gad.1054703","article-title":"Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor","volume":"17","author":"Jacks","year":"2003","journal-title":"Genes Dev"},{"key":"176","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.neuroscience.2007.05.008","article-title":"Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile","volume":"147","author":"Tischler","year":"2007","journal-title":"Neuroscience"},{"key":"177","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Toledo","year":"2010","journal-title":"Nat Genet"},{"key":"178","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"179","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-10-0758","article-title":"A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma","volume":"164","author":"Gimenez-Roqueplo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2012.04421.x","article-title":"Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma","volume":"77","author":"Igarashi","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"181","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/imj.12088","article-title":"Novel mutation in the TMEM127 gene associated with phaeochromocytoma","volume":"43","author":"Conaglen","year":"2013","journal-title":"Intern Med J"},{"key":"182","doi-asserted-by":"crossref","first-page":"E1279","DOI":"10.1210\/jc.2011-0114","article-title":"Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites","volume":"96","author":"Eng","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10974-013-9367-4","article-title":"The mechanical activation of mTOR signaling: an emerging role for late endosome\/lysosomal targeting","volume":"35","author":"Hornberger","year":"2014","journal-title":"J Muscle Res Cell Motil"},{"key":"184","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1091\/mbc.e09-09-0756","article-title":"The late endosome is essential for mTORC1 signaling","volume":"21","author":"Backer","year":"2010","journal-title":"Mol Biol Cell"},{"key":"185","doi-asserted-by":"crossref","first-page":"20913","DOI":"10.1074\/jbc.M111.334060","article-title":"Rab5 proteins regulate activation and localization of target of rapamycin complex 1","volume":"287","author":"Saltiel","year":"2012","journal-title":"J Biol Chem"},{"key":"186","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/hmg\/ddt638","article-title":"The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function","volume":"23","author":"Dahia","year":"2014","journal-title":"Hum Mol Genet"},{"key":"187","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.1922","article-title":"Regulation of endocytosis via the oxygen-sensing pathway","volume":"15","author":"Teh","year":"2009","journal-title":"Nat Med"},{"key":"188","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1073\/pnas.1112129109","article-title":"Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1","volume":"109","author":"Park","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"189","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Eisenman","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"190","doi-asserted-by":"crossref","first-page":"2353560","DOI":"10.1155\/2016\/2353560","article-title":"The dysregulation of polyamine metabolism in colorectal cancer is associated with overexpression of c-Myc and C\/EBPbeta rather than enterotoxigenic Bacteroides fragilis infection","volume":"2016","author":"Kudryavtseva","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"191","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Inglada-P\u00e9rez","year":"2011","journal-title":"Nat Genet"},{"key":"192","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/gad.6.1.71","article-title":"Myc and Max associate in vivo","volume":"6","author":"Eisenman","year":"1992","journal-title":"Genes Dev"},{"key":"193","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MYC: a heritable breakup","volume":"72","author":"Robledo","year":"2012","journal-title":"Cancer Res"},{"key":"194","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cen.12218","article-title":"Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma\/paraganglioma patients with clinical characteristics of hereditary syndromes","volume":"79","author":"Neumann","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10689-013-9666-3","article-title":"MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours","volume":"13","author":"Bj\u00f6rklund","year":"2014","journal-title":"Fam Cancer"},{"key":"196","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0092-8674(94)90012-4","article-title":"KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria","volume":"79","author":"Hirokawa","year":"1994","journal-title":"Cell"},{"key":"197","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(01)00363-4","article-title":"Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta","volume":"105","author":"Hayashi","year":"2001","journal-title":"Cell"},{"key":"198","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","author":"Look","year":"2008","journal-title":"Genes Dev"},{"key":"199","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00439-008-0553-1","article-title":"A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors","volume":"124","author":"Dahia","year":"2008","journal-title":"Hum Genet"},{"key":"200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/332085a0","article-title":"Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma","volume":"332","author":"Nordenskjold","year":"1988","journal-title":"Nature"},{"key":"201","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/hmg\/6.7.1169","article-title":"Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states","volume":"6","author":"Manickam","year":"1997","journal-title":"Hum Mol Genet"},{"key":"202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2174\/156652408786733702","article-title":"Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective","volume":"8","author":"Hua","year":"2008","journal-title":"Curr Mol Med"},{"key":"203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ejhg.2013.128","article-title":"A MEN1 syndrome with a paraganglioma","volume":"22","author":"Archambeaud","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1043-2760(00)00372-6","article-title":"Multiple endocrine neoplasia type 1: new clinical and basic findings","volume":"12","author":"Marx","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"205","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Gimm","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"206","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1067\/msy.2099.101376","article-title":"Screening for MEN1 mutations in patients with atypical endocrine neoplasia","volume":"126","author":"Lee","year":"1999","journal-title":"Surgery"},{"key":"207","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccr.2005.06.015","article-title":"Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer","volume":"8","author":"Schlisio","year":"2005","journal-title":"Cancer Cell"},{"key":"208","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.200112129","article-title":"c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation","volume":"158","author":"Carter","year":"2002","journal-title":"J Cell Biol"},{"key":"209","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0092-8674(95)90470-0","article-title":"Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons","volume":"82","author":"Parada","year":"1995","journal-title":"Cell"},{"key":"210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","article-title":"Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription","volume":"96","author":"Burns","year":"1999","journal-title":"Cell"},{"key":"211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/1541-7786.MCR-07-0180","article-title":"c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation","volume":"6","author":"Le\u00f3n","year":"2008","journal-title":"Mol Cancer Res"},{"key":"212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/381785a0","article-title":"Functional receptor for GDNF encoded by the c-ret proto-oncogene","volume":"381","author":"Arum\u00e4e","year":"1996","journal-title":"Nature"},{"key":"213","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-4388(99)00048-3","article-title":"The GDNF family ligands and receptors - implications for neural development","volume":"10","author":"Milbrandt","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"214","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/5.12.2023","article-title":"De novo mutation of GDNF, ligand for the RET\/GDNFR-alpha receptor complex, in Hirschsprung disease","volume":"5","author":"Mulligan","year":"1996","journal-title":"Hum Mol Genet"},{"key":"215","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/hmg\/6.7.1051","article-title":"Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL","volume":"6","author":"Maher","year":"1997","journal-title":"Hum Mol Genet"},{"key":"216","first-page":"310","article-title":"Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET\/GDNF receptor alpha complex, in sporadic phaeochromocytomas","volume":"57","author":"Eng","year":"1997","journal-title":"Cancer Res"},{"key":"217","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"218","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/bjc.1998.177","article-title":"Mutations of K-ras oncogene in human adrenal tumours in Taiwan","volume":"77","author":"Lee","year":"1998","journal-title":"Br J Cancer"},{"key":"219","first-page":"1596","article-title":"Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers","volume":"51","author":"Brodeur","year":"1991","journal-title":"Cancer Res"},{"key":"220","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0022-5347(17)36397-8","article-title":"Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas","volume":"149","author":"Chang","year":"1993","journal-title":"J Urol"},{"key":"221","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.1992.tb02722.x","article-title":"ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism","volume":"83","author":"Itakura","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"222","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","author":"Maher","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"223","first-page":"794187","article-title":"Paragangliomas\/Pheochromocytomas: clinically oriented genetic testing","volume":"2014","author":"Bugalho","year":"2014","journal-title":"Int J Endocrinol"},{"key":"224","first-page":"138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis","volume":"2015","author":"Abbs","year":"2015","journal-title":"Int J Endocrinol"},{"key":"225","first-page":"114","article-title":"A new syndrome: mental subnormality and nasal papillomata","volume":"13","author":"Costello","year":"1977","journal-title":"Aust Paediatr J"},{"key":"226","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Bj\u00f6rklund","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"227","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","article-title":"H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series","volume":"99","author":"Robledo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"228","first-page":"81","article-title":"The KRAS oncogene: past, present, and future","volume":"1756","author":"Kranenburg","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"229","doi-asserted-by":"publisher","first-page":"53959","DOI":"10.18632\/oncotarget.979","article-title":"Important molecular genetic markers of colorectal cancer","volume":"7","author":"Krasnov","year":"2016","journal-title":"Oncotarget"},{"key":"230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Zhang","year":"2006","journal-title":"Nat Genet"},{"key":"231","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2826.2008.01755.x","article-title":"Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas","volume":"20","author":"Karapandza","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"232","first-page":"65","article-title":"GNAS locus and pseudohypoparathyroidism","volume":"63","author":"J\u00fcppner","year":"2005","journal-title":"Horm Res"},{"key":"233","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ando.2015.03.011","article-title":"Genetic and epigenetic defects at the GNAS locus cause different forms of pseudohypoparathyroidism","volume":"76","author":"J\u00fcppner","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"234","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11914-015-0268-x","article-title":"GNAS spectrum of disorders","volume":"13","author":"Bastepe","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"235","first-page":"1702","article-title":"G protein gene mutations in patients with multiple endocrinopathies","volume":"80","author":"Harris","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"236","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3858\/emm.2010.42.7.050","article-title":"Integrative epigenomic and genomic analysis of malignant pheochromocytoma","volume":"42","author":"Wadelius","year":"2010","journal-title":"Exp Mol Med"},{"key":"237","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.2274789","article-title":"Genetic mechanisms of tumor suppression by the human p53 gene","volume":"250","author":"Lee","year":"1990","journal-title":"Science"},{"key":"238","first-page":"500","article-title":"The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma","volume":"40","author":"Johnson","year":"2008","journal-title":"Pathology"},{"key":"239","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00384-008-0455-7","article-title":"hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features","volume":"23","author":"Ho","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"240","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0748-7983(95)95262-4","article-title":"Expression of p53 and its relationship with human papillomavirus in penile carcinomas","volume":"21","author":"Srivastava","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"241","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F","article-title":"Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients","volume":"74","author":"Wong","year":"1997","journal-title":"Int J Cancer"},{"key":"242","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Miller","year":"1988","journal-title":"Cancer Res"},{"key":"243","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Sandrini","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"244","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jcp.54.6.443","article-title":"The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas","volume":"54","author":"Lam","year":"2001","journal-title":"J Clin Pathol"},{"key":"245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3801013","article-title":"Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas","volume":"21","author":"de Krijger","year":"2008","journal-title":"Mod Pathol"},{"key":"246","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/sj.onc.1202737","article-title":"Tissue-specific alternative splicing in the human INK4a\/ARF cell cycle regulatory locus","volume":"18","author":"Jones","year":"1999","journal-title":"Oncogene"},{"key":"247","first-page":"2298","article-title":"Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors","volume":"58","author":"Vidaud","year":"1998","journal-title":"Cancer Res"},{"key":"248","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.1996.tb02065.x","article-title":"Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas","volume":"45","author":"Cross","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2004-830522","article-title":"Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas","volume":"113","author":"Brauckhoff","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"250","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Lam","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"761","key":"251","first-page":"763","article-title":"Cancer-susceptibility genes. Gatekeepers and caretakers","volume":"386","author":"Vogelstein","year":"1997","journal-title":"Nature"},{"key":"252","first-page":"145","article-title":"Hereditary breast cancer: clinical, pathological and molecular characteristics","volume":"8","author":"Kruse","year":"2014","journal-title":"Breast Cancer (Auckl)"},{"issue":"121","key":"253","first-page":"2474","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Litton","year":"2015","journal-title":"Cancer"},{"key":"254","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1096-8628(20010122)98:3<277::AID-AJMG1082>3.0.CO;2-Q","article-title":"Adrenal tumors in BRCA1\/BRCA2 mutation carriers","volume":"98","author":"Goldberg","year":"2001","journal-title":"Am J Med Genet"},{"key":"255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Gaudino","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"256","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.1381306","article-title":"Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes","volume":"20","author":"Livingston","year":"2006","journal-title":"Genes Dev"},{"key":"257","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity","volume":"69","author":"Ohta","year":"2009","journal-title":"Cancer Res"},{"key":"258","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Pirun","year":"2011","journal-title":"Nat Genet"},{"key":"259","first-page":"116","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Scolyer","year":"2013","journal-title":"Pathology"},{"key":"260","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/pcmr.12006","article-title":"A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma","volume":"25","author":"Brown","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"261","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/epi.23271","article-title":"ATRX: the case of a peculiar chromatin remodeler","volume":"8","author":"Bernstein","year":"2013","journal-title":"Epigenetics"},{"key":"262","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Daber","year":"2015","journal-title":"Nat Commun"},{"key":"263","first-page":"8","article-title":"MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing","author":"Matzuk","year":"2010","journal-title":"PLoS Biol"},{"key":"264","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8935-2-5","article-title":"The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis","volume":"2","author":"Stewart","year":"2009","journal-title":"Epigenetics Chromatin"},{"key":"265","doi-asserted-by":"crossref","first-page":"17603","DOI":"10.1073\/pnas.1208807109","article-title":"Global identification of MLL2-targeted loci reveals MLL2\u2019s role in diverse signaling pathways","volume":"109","author":"Papadopoulos","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"266","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng.646","article-title":"Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome","volume":"42","author":"Smith","year":"2010","journal-title":"Nat Genet"},{"key":"267","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Yasuno","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"268","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-05-2720","article-title":"Oncogenic BRAF is required for tumor growth and maintenance in melanoma models","volume":"66","author":"Seshagiri","year":"2006","journal-title":"Cancer Res"},{"key":"269","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/onc.2012.642","article-title":"Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation","volume":"33","author":"Xu","year":"2014","journal-title":"Oncogene"},{"key":"270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","article-title":"HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity","volume":"11","author":"Simon","year":"2007","journal-title":"Cancer Cell"},{"key":"271","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","article-title":"High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands","volume":"81","author":"Bayley","year":"2012","journal-title":"Clin Genet"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T04:35:45Z","timestamp":1749962145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":271,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4,11]]}},"alternative-id":["15201","28187001"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15201","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}